Last week in separate deals with the GAVI Alliance, the drug companies Pfizer and GlaxoSmithKline (GSK) agreed to increase sales of cut-price pneumonia vaccines by 180 million doses, a 50% increase from previous commitments.

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.

Gift giving can become tiresome. There is the shopping, and the wondering if your online shipment will arrive in time, or worse, actually going to a mall. There is the wrapping, but remember, not before you fly. Then, of course, there is the deflated feeling that it really doesn’t matter.

In an op-ed published Friday, Sabin president Peter Hotez, M.D., Ph.D., and his Baylor College of Medicine colleague, William Brinkley, Ph.D., applaud the dramatic gains Texas institutions have made to become leaders among the global scientific community. They cite the routinely high ranking of public and private Texas universities as well as a voter approved amendment to start the Cancer Prevention and Research Institute of Texas (CPRIT).

Pages